Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.

Autor: Raoof M; Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Corr SJ; Department of Surgery, Baylor College of Medicine, Houston, TX, USA; Department of Chemistry and Richard E. Smalley Institute for Nanoscale Science & Technology, Rice University, Houston, TX, USA., Zhu C; Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Cisneros BT; Department of Surgery, Baylor College of Medicine, Houston, TX, USA; Department of Chemistry and Richard E. Smalley Institute for Nanoscale Science & Technology, Rice University, Houston, TX, USA., Kaluarachchi WD; Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Phounsavath S; Department of Surgery, Baylor College of Medicine, Houston, TX, USA; Department of Chemistry and Richard E. Smalley Institute for Nanoscale Science & Technology, Rice University, Houston, TX, USA., Wilson LJ; Department of Chemistry and Richard E. Smalley Institute for Nanoscale Science & Technology, Rice University, Houston, TX, USA., Curley SA; Department of Surgery, Baylor College of Medicine, Houston, TX, USA; Department of Mechanical Engineering and Materials Science Rice University, Houston, TX, USA. Electronic address: steven.curley@bcm.edu.
Jazyk: angličtina
Zdroj: Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2014 Aug; Vol. 10 (6), pp. 1121-30. Date of Electronic Publication: 2014 Mar 17.
DOI: 10.1016/j.nano.2014.03.004
Abstrakt: Hepatocellular carcinoma (HCC) is one of the most lethal and chemo-refractory cancers, clearly, alternative treatment strategies are needed. We utilized 10nm gold nanoparticles as a scaffold to synthesize nanoconjugates bearing a targeting antibody (cetuximab, C225) and gemcitabine. Loading efficiency of gemcitabine on the gold nanoconjugates was 30%. Targeted gold nanoconjugates in combination with RF were selectively cytotoxic to EGFR expressing Hep3B and SNU449 cells when compared to isotype particles with/without RF (P<0.05). In animal experiments, targeted gold nanoconjugates halted the growth of subcutaneous Hep3B xenografts in combination with RF exposure (P<0.05). These xenografts also demonstrated increased apoptosis, necrosis and decreased proliferation compared to controls. Normal tissues were unharmed. We have demonstrated that non-invasive RF-induced hyperthermia when combined with targeted delivery of gemcitabine is more effective and safe at dosages ~275-fold lower than the current clinically-delivered systemic dose of gemcitabine.
From the Clinical Editor: In a model of hepatocellular carcinoma, the authors demonstrate that non-invasive RF-induced hyperthermia applied with cetuximab targeted delivery of Au NP-gemcitabine conjugate is more effective and safe at dosages ~ 275-fold lower than the current clinically-used systemic dose of gemcitabine.
(Copyright © 2014 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: